Susunod

Auto-play

Upfront Immunotherapy for Metastatic Kidney Cancer

0 Mga view • 06/26/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

Panelists Robert A. Figlin, MD, and Eric Jonasch, MD, provide insight on the implications of frontline trials for immunotherapy and cabozantinib use, and the rationale for combination trials for metastatic kidney cancer.

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play